Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 162, Issue 3, Pages 966-970Publisher
AMER THORACIC SOC
DOI: 10.1164/ajrccm.162.3.9912054
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL44846] Funding Source: Medline
- NIAID NIH HHS [R01 AI25780] Funding Source: Medline
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044846] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025780] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Impaired adaptive immunity is the hallmark of AIDS, but the effects of human immunodeficiency virus type 1 (HIV-1) infection on innate immunity are less clear. Cryptococcus neoformans (CN) is a common AIDS-related fungal pathogen acquired by inhalation. Alveolar macrophages (AM phi) comprise the initial host defense in cryptococcosis and they may arrest infection before dissemination occurs. We hypothesized that HIV-1 infection of AM phi impairs their anti-cryptococcal activity. This was tested by infection of normal AM phi with the M-tropic strain HIV-1(Bal). Two weeks postinfection we measured fungistatic activity against CN by colony counting, binding, and internalization of CN by confocal microscopy and AM phi cell viability by Alamar Blue assay. Uninfected AM phi from most donors demonstrated innate fungicidal activity against CN. In HIV-1-infected AM phi, there was a significant reduction, and in most cases loss, of fungicidal activity compared with the uninfected AM phi. The reduced antifungal activity was not due to any cytotoxic effect of HIV-1, and HIV-1 infection did not impair binding or internalization of yeast by AM phi. Thus, the innate fungicidal activity of primary human AM phi is impaired after HIV-1 infection in vitro by a mechanism involving a defect of intracellular antimicrobial processing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available